ArticleBMC ophthalmology2026

Short-term treatment outcomes of the ranibizumab biosimilar CKD-701 for vitreous hemorrhage secondary to proliferative diabetic retinopathy.

So Hyun Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.